Filgotinib maintained a favorable safety and efficacy profile for up to 8 years among patients with RA who participated in the DARWIN 3 LTE.
The Fund invests its assets directly, or indirectly through Derivatives or Collective Investment Schemes in the following: between 30% and 70% in shares in companies which are, at the time of purchase ...
Department of Environmental Chemistry, IDAEA-CSIC, Barcelona, Catalunya 08034, Spain Department of Evolutionary Biology, Ecology and Environmental Sciences, Faculty of Biology, Universitat de ...